Australia markets closed

4D Molecular Therapeutics, Inc. (FDMT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
26.380.00 (0.00%)
At close: 04:00PM EDT
26.15 -0.23 (-0.87%)
After hours: 06:14PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
249,108
52,351
153,001
276,726
Other short-term investments
39,124
161,203
94,776
0
Total cash
288,232
213,554
247,777
276,726
Net receivables
-
0
47
1,486
Other current assets
8,356
6,957
8,456
-
Total current assets
296,588
220,511
256,280
282,656
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
43,597
43,075
34,278
8,917
Accumulated depreciation
-11,932
-7,728
-5,325
-3,844
Net property, plant and equipment
31,665
35,347
28,953
5,073
Equity and other investments
10,954
4,908
67,652
0
Other long-term assets
684
1,080
602
602
Total non-current assets
43,303
41,335
97,207
5,675
Total assets
339,891
261,846
353,487
288,331
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
3,515
3,322
4,764
1,787
Accrued liabilities
12,014
8,870
7,744
8,371
Deferred revenues
273
884
2,599
6,586
Total current liabilities
18,951
15,731
16,338
16,744
Non-current liabilities
Deferred revenues
972
1,076
2,491
13,226
Other long-term liabilities
248
21
120
1,852
Total non-current liabilities
13,111
14,778
18,042
15,200
Total liabilities
32,062
30,509
34,380
31,944
Stockholders' equity
Common stock
4
3
3
3
Retained earnings
-415,327
-314,490
-206,996
-135,679
Accumulated other comprehensive income
16
-1,196
-423
0
Total stockholders' equity
307,829
231,337
319,107
256,387
Total liabilities and stockholders' equity
339,891
261,846
353,487
288,331